Effects of in vivo treatment with FK506 on natural killer cells in rats.
Markus
P M
PM
Department of Surgery, Pittsburgh Cancer Institute, University of Pittsburgh, Pennsylvania 15261.
Van den Brink
M R
MR
Luchs
B A
BA
Fung
J J
JJ
Starzl
T E
TE
Hiserodt
J C
JC
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000920:Antibody-Dependent Cell Cytotoxicity; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007376:Interleukin-2 / Q000494:pharmacology; D007694:Killer Cells, Natural / Q000187:drug effects*; D007959:Lymphocyte Culture Test, Mixed; D051381:Rats; D011916:Rats, Inbred F344; D016559:Tacrolimus
D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D007376:Interleukin-2; D016559:Tacrolimus